Phacilitate Leaders Forum

Phacilitate Leaders Europe Agenda 2018


New tests to predict response to immunotherapy

Immuno-Oncology Frontiers Europe

·         New combinations of biomarkers are making prediction more accurate

·         New doluble ctDNA for better clinical prediction for PD1 therapy

Suso Platero, Executive Director - Covance
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd